Merkoçi Research Group

Merkoçi Research Group List of publications (Google Scholar):
https://scholar.google.es/citations?hl=en&user=hF6hPeIAAAAJ&v

The research at Merkoçi Group focuses on discovering and technological development of the cutting edge nanotechnology and nanomaterials based simple biosensing platforms by employing and controlling their architectures at both nano and macro scales with the objective to link together nano and macro worlds.

We are pleased to welcome new members to our group.Vanessa N. Ataide is a postdoctoral fellow at the University of São P...
13/04/2026

We are pleased to welcome new members to our group.

Vanessa N. Ataide is a postdoctoral fellow at the University of São Paulo, São Paulo campus (Brazil). She is part of the Instrumental Analytical Chemistry Research Group. During her time with us, she will work on coupling carbon-based electrodes with lateral flow assays for the detection of cancer biomarkers.

Beatrice Francalanci is a PhD candidate in Industrial Engineering at the University of Florence, with a background in Biomedical and Mechanical Engineering. She works in the Biomedical and Robotics Lab, led by Prof. Filippo Cavallo, and will join us for a six-month visiting period. Her research focuses on portable electrochemical sensing devices for non-invasive biomarker detection.

We are delighted to welcome them and look forward to fruitful collaborations. We hope they will have a productive and enjoyable time with us.

ICREA Prof. Arben Merkoçi, leader of the ICN2 Nanobioelectronics and Biosensors Group, has reached an h-index of #100 a...
24/03/2026

ICREA Prof. Arben Merkoçi, leader of the ICN2 Nanobioelectronics and Biosensors Group, has reached an h-index of #100 according to Google Scholar, marking a significant milestone in his career. This achievement reflects the sustained efforts of both current and former members of his research group over more than two decades.

The h-index is a widely recognised metric that captures both the productivity and citation impact of a researcher’s publications. An h-index of 100 means that Prof. Merkoçi has authored at least 100 scientific papers that have each received 100 or more citations, placing him among a select group of highly cited scientists worldwide. In total, he has accumulated more than 38,000 citations across a body of work comprising over 300 peer-reviewed publications since 2007.

According to the Research.com ranking, Prof. Merkoçi is the number one scientist in the field of Electronics and Electrical Engineering in Spain. He was also recently invited to join the Institut d’Estudis Catalans in recognition of his outstanding research contributions in Catalonia, particularly in the fields of nanotechnology and biosensors. In addition, he serves as Editor-in-Chief of Biosensors and Bioelectronics (impact factor 10.5), the leading journal in the field.

The research carried out by Prof. Merkoçi’s group focuses on integrating cutting-edge nanotechnology into next-generation biosensors, enhancing their performance while addressing key challenges such as sustainability, portability, ease of use and cost-effective production. Their work spans areas such as graphene stamping, inkjet printing and paper-based microfluidics, with applications in healthcare and environmental monitoring. This expertise has also led to the creation of two spin-off companies: Graphenicalab, focused on graphene-based devices, and Paperdrop Diagnostics, dedicated to the development of rapid diagnostic tests for emerging diseases.

At ICN2, we would like to congratulate Prof. Arben Merkoçi and his research group on this important achievement.

More info at: https://icn2.cat/en/news/5593-prof-arben-merkoci-reaches-an-h-index-of-100

Last day to register for the upcoming webinar “The Optimization of Buffers for Lateral Flow Assays” to learn about buffe...
23/03/2026

Last day to register for the upcoming webinar “The Optimization of Buffers for Lateral Flow Assays” to learn about buffer impact on the performance of lateral flow assays.

Speaker: Dr. Andrew Piper
Date: March 24, 2026
Free Virtual Event

We are pleased to welcome two new members to our group.Gustavo Silveira Toldo is a PhD student from the University of Sã...
13/03/2026

We are pleased to welcome two new members to our group.

Gustavo Silveira Toldo is a PhD student from the University of São Paulo, Ribeirão Preto Campus. Gustavo is part of the Laboratory of Bioanalytics and Nanosystems (LBioNano) in Brazil. During his time with us, he will work on engineering printed conductive polymers and gold nanorods for enhanced photo-electrocatalytic processes, strengthening collaborations in nanomaterials and bioanalytical technologies.

Alexia Rubio joins us from the Autonomous University of Barcelona (UAB), where she completed her Bachelor’s degree in Biochemistry and is currently finishing her Master’s in Advanced Biotechnology. She will be working with the Nanosensors and Nanobioelectronics Group until June as part of her Master’s thesis. Her research focuses on developing a CRISPR-powered graphene-based platform for HPV detection, contributing to innovative approaches in biosensing and molecular diagnostics.

Our Winter Seminar has successfully come to an end! It was a great opportunity to exchange ideas, have meaningful discus...
12/03/2026

Our Winter Seminar has successfully come to an end! It was a great opportunity to exchange ideas, have meaningful discussions, and connect with both existing and new members. The session was filled with thoughtful conversations, fresh perspectives, and collaborative energy.

A warm welcome to our new members who joined us and contributed to the discussions. We’re excited about the ideas shared and the opportunities ahead.

Thank you to everyone who participated and helped make this seminar engaging and productive. Looking forward to the next steps together!

12/03/2026

Enjoying sun and international pica-pica lunch as a group, sharing different foods, cultures, and conversations together. A perfect way to celebrate collaboration and teamwork after a productive seminar 🌸

ICN2 presents latest biosensor advances at 2D-BioPAD consortium meetingResearchers from the Nanobioelectronics and Biose...
11/03/2026

ICN2 presents latest biosensor advances at 2D-BioPAD consortium meeting
Researchers from the Nanobioelectronics and Biosensors Group at ICN2 attended the 6th consortium meeting of the Horizon Europe project 2D-BioPAD, held on 3–4 March 2026 in Mannheim, Germany. The meeting brought together project partners both in person and online to review recent progress and coordinate the next phase of the project. The event was hosted at the Central Institute of Mental Health (ZI).
ICN2 was represented by Arben Merkoçi, Ruslan Álvarez, Marianna Rossetti and Danilo Echeverri. During the meeting, Marianna Rossetti and Danilo Echeverri presented the latest advances achieved by the ICN2 team, contributing to the development of graphene-based materials and biosensor technologies within the project.
Consortium partners reported progress achieved during the fifth project semester (October 2025 – March 2026), including developments in aptamer selection for Alzheimer’s disease biomarkers, magnetic nanoparticles, graphene materials, and biosensing platforms. Updates were also presented on the development of both electrochemical and graphene field-effect transistor (GFET) biosensors, which will be integrated into the 2D-BioPAD diagnostic device.
Further discussions focused on the integration of biosensors into the system architecture, as well as preparations for retrospective and prospective clinical pilot studies using real plasma samples. Ethical approvals for the retrospective study have already been obtained, and partners are currently coordinating sample benchmarking and shipment procedures.
The meeting also addressed communication, dissemination and exploitation activities, including collaboration with other research initiatives and the planning of future workshops and policy engagement.
Over the coming months, the consortium will focus on finalising key deliverables, testing biosensors with plasma samples, and advancing preparations for clinical validation. The next consortium meeting is scheduled for November 2026 in Kuopio, Finland, where partners will review progress and prepare for the project’s second review.

We are glad to announce the kick-off of the MITEST project is funded by BIST seed funding award. Congratulations Andrew ...
09/03/2026

We are glad to announce the kick-off of the MITEST project is funded by BIST seed funding award. Congratulations Andrew and collaborators! It’s great to see this collaboration between and , supported by , aiming to develop point-of-care diagnostics for mitochondrial diseases.
Click here to read more: https://lnkd.in/ezvkFiDg

UniversityofOxford BIST

We are delighted to have spent two great days with the Prof Corrigan and his group as part of the British Council Spring...
25/02/2026

We are delighted to have spent two great days with the Prof Corrigan and his group as part of the British Council Springboard grant to promote Spanish-U.K. collaborations. A big thanks to Dr Veerrappan Mani for helping to co-write the grant and organise these events. We are looking forward to the return trip to Glasgow and the Unviersity of Strathclyde as we build towards future European grant applications together.

We are delighted to have spent two great days with Prof. Corrigan and his group as part of the British Council Springboa...
25/02/2026

We are delighted to have spent two great days with Prof. Corrigan and his group as part of the British Council Springboard grant to promote Spanish-U.K. collaborations. A big thanks to Dr. Veerappan Mani for helping to co-write the grant and organise these events. We are looking forward to the return trip to Glasgow and the University of Strathclyde as we build towards future European grant applications together.

Dirección

ICN2, Campus UAB
Barberà Del Vallés
08193

Página web

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Merkoçi Research Group publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Atajos

Compartir